药械

订阅

MedSci主页 / 所有栏目 / 药械

194家上市医药企业赚钱能力大排行

2018-04-23 佚名 医药地方台

上市医药企业营业收入智飞生物
关注

在这194家医药企业中，除了上海医药营收达1308亿元外，有16家药企营收超百亿元……

2017年年报披露已经接近尾声了，在政策和整体环境影响下，药企们都交出了怎样的成绩单呢？

根据相关数据不完全统计，截至4月20日，有194家药企发布2017年年报。从营业收入看，在这194家医药企业中，除了上海医药营收达1308亿元外，有16家药企营收超百亿元，包括国药一致（413亿元）、国药股份（363亿元）、中国医药（301亿元）等。

营收同比增长在100%以上的药企有6家，分别是冠福股份（997.36%）、顺昊生物（263.05%）、海融医药（227.64%）、同济医药（203.42%）、智飞生物（201.06%）、灵康药业（110.01%）。



从净利润看，有21家药企2017年净利润超10亿元，排名前三的是丽珠集团（44.29亿元）、上海医药（35.21亿元）、恒瑞医药（32.17亿元）。亏损企业有3家，分别是迈迪生物（-0.058亿元）、元延医药（-0.08亿元）、海融医药（-0.1亿元）。

净利润同比增长超1000%的药企有2家，分别是智飞生物（1229.25%）、祁药股份（1029.85%）；同比增长在999-100%间的有17家，包括北陆药业（625.4%）、丽珠集团（464.63%）、辰星药业（375.04%）。



版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935728, encodeId=7e361935e282a, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Aug 12 20:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409495, encodeId=0b61140949550, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456176, encodeId=082c14561e606, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495559, encodeId=8a0d149555939, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=)]
    2018-08-12 12498761m56暂无昵称

    #医药企业#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1935728, encodeId=7e361935e282a, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Aug 12 20:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409495, encodeId=0b61140949550, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456176, encodeId=082c14561e606, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495559, encodeId=8a0d149555939, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=)]
    2018-04-25 cathymary

    #医药#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1935728, encodeId=7e361935e282a, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Aug 12 20:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409495, encodeId=0b61140949550, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456176, encodeId=082c14561e606, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495559, encodeId=8a0d149555939, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=)]
    2018-04-25 hyf030

    #企业#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1935728, encodeId=7e361935e282a, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Aug 12 20:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409495, encodeId=0b61140949550, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456176, encodeId=082c14561e606, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495559, encodeId=8a0d149555939, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Wed Apr 25 01:15:00 CST 2018, time=2018-04-25, status=1, ipAttribution=)]
    2018-04-25 wujh_7312822

    #排行#

    0